Affiliation:
1. Military Medical Academy named after S.M. Kirov
2. Military Medical Academy named after S.M. Kirov; Children’s Research and Clinical Center for Infectious Diseases
3. Children’s Research and Clinical Center for Infectious Diseases
Abstract
Since the description of the first clinical cases of the most common neurodegenerative diseases, numerous hypotheses have been proposed for their development. At the same time, the failure of therapeutic strategies in various directions of clinical research indicates the fallacy of most theories. In this regard, in recent years, various infectious agents are increasingly considered as a trigger of neuronal inflammation and a factor inducing the onset of the neurodegenerative process. Infectious agents differ in their mechanisms of invasion into the central nervous system and can even enter the brain perineurally. Reactivation of latent viral infection induces the production of viral proteins and the accumulation of abnormal proteins that are markers of Alzheimer’s disease and Parkinson’s disease. Both bacterial (chlamydia, causative agents of chronic periodontitis, E. coli) and viral (herpes viruses, noroviruses) infectious agents are considered. However, for the development of neurodegeneration, it is not enough just a simple invasion and reactivation of the infectious process: the genetic characteristics of the main histocompatibility complex also play a huge role. Currently, several studies have been initiated on the possible efficacy of antibacterial and antiviral drugs in Alzheimer’s disease. Data obtained over the past year suggests that the brain may act as a target for SARS-CoV-2. Neurological manifestations of COVID-19 can occur as a result of both the direct cytopathic action of the pathogen and the activation of neuroinflammation, accompanied by a violation of the integrity of the blood-brain barrier. Further study of the molecular and cellular mechanisms of neuroinflammation and neurodegeneration in COVID-19 will form the basis for the development of treatments for neurological complications.
Publisher
Medical Informational Agency Publishers
Subject
Psychiatry and Mental health,Neurology (clinical),Neurology
Reference54 articles.
1. Litvinenko I.V., Emelin A.Yu., Lobzin V.Yu., Kolmakova K.A., Naumov K.M., Lupanov I.A. i dr. Amiloidnaya gipoteza bolezni Al'tsgeimera: proshloe i nastoyashchee, nadezhdy i razocharovaniya. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2019;11(3):4–10. [Litvinenko I.V., Emelin A.Yu., Lobzin V.Yu., Kolmakova K.A., Naumov K.M., Lupanov I.A. et al. The amyloid hypothesis of Alzheimer’s disease: past and present, hopes and disappointments. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):4–10. (In Russ.)]. https://doi.org/10.14412/2074-2711-2019-3-4-10
2. Lewandowski G., Zimmerman M.N., Denk L.L., Porter D.D., Prince G.A. Herpes simplex type 1 infects and establishes latency in the brain and trigeminal ganglia during primary infection of the lip in cotton rats and mice. Arch. Virol. 2002;147:167–79. https://doi.org/10.1007/s705-002-8309-9
3. Mori I., Goshima F., Ito H., Koide N., Yoshida T., Yokochi T. et al. The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus. Virology. 2005;334:51–8.
4. Prokop S., Lee V.M.Y., Trojanowski J.Q. Neuroimmune interactions in Alzheimer’s disease-New frontier with old challenges? Prog Mol Biol Transl Sci. 2019;168:183–201. https://doi:10.1016/bs.pmbts.2019.10.002
5. Lobzin V.Yu., Litvinenko I.V., Skripchenko N.V., Skripchenko E.Yu., Strumentova E.S. Rol' vozbuditelei bakterial'nykh i virusnykh infektsii v initsiatsii neirodegenerativnykh zabolevanii. Zhurnal infektologii. 2021;13(1–1):77–78. [Lobzin V.Yu., Litvinenko I.V., Skripchenko N.V., Skripchenko E.Yu., Strumentova E.S. The role of causative agents of bacterial and viral infections in the initiation of neurodegenerative diseases. Journal Infectology. 2021;13(1– 1):77–78. (In Russ.)].
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献